| Sather Family Dental, Llc | |
|
118 Douglas St Chetek WI 54728-9508 | |
| (715) 925-4545 | |
| (715) 925-4546 |
| Full Name | Sather Family Dental, Llc |
|---|---|
| Speciality | Dentist |
| Location | 118 Douglas St, Chetek, Wisconsin |
| Authorized Official Name and Position | Nik E Sather (OWNER) |
| Authorized Official Contact | 7159254545 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Sather Family Dental, Llc 118 Douglas St P.o. Box 777 Chetek WI 54728-9508 Ph: (715) 925-4545 | Sather Family Dental, Llc 118 Douglas St Chetek WI 54728-9508 Ph: (715) 925-4545 |
| NPI Number | 1528399730 |
|---|---|
| Provider Enumeration Date | 01/28/2010 |
| Last Update Date | 07/11/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528399730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 5581-015 (Wisconsin) | Primary |
News Archive
University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
New research being presented at the 2010 FIP Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical Scientists Annual Meeting and Exposition will highlight a targeted inhalable dry powder vaccine that may prove preferable in terms of needle avoidance and expected lower cost than the current commercial human papillomavirus (HPV) vaccine used throughout the world.
In today's headlines, the Supreme Court chronicles continue, with reports detailing what happened during yesterday's opening-day oral arguments and previewing what's on tap for today.
The socioeconomic status of a country has long been considered a potentially significant factor in the availability of high-quality health-care interventions and even a determinant of long-term patient outcomes. A new study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation reports that in Europe, socioeconomic factors have a direct correlation to the rates and outcomes of stem cell transplantation for patients with acute myeloid leukemia (AML).
› Verified 1 days ago